• Explore /
  • Poster
  • / TRIOC: A randomised parallel group double-blind phase II study to assess the activity of MVA-5T4 vaccine versus placebo in patients with relapsed asymptomatic epithelial ovarian, fallopian tube, or primary peritoneal cancer.

TRIOC: A randomised parallel group double-blind phase II study to assess the activity of MVA-5T4 vaccine versus placebo in patients with relapsed asymptomatic epithelial ovarian, fallopian tube, or primary peritoneal cancer.

Abstract Poster

Authors

null

Agnieszka Michael

University of Surrey, Guildford, United Kingdom

Agnieszka Michael , Rosemary Lord , Geoff Hall , Louise Hanna , Anjana Anand , Axel Walther , Shibani Nicum , Andrew R. Clamp , Rebecca Sophie Kristeleit , Alan Hackshaw , Gita Parmar , Yen Ngai , Laura Farrelly , Sharadah Essapen , Iain A. McNeish , Richard Harrop , Jonathan A. Ledermann

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2016 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Gynecologic Cancer

Track

Gynecologic Cancer

Sub Track

Ovarian Cancer

Clinical Trial Registration Number

NCT01556841

Citation

J Clin Oncol 34, 2016 (suppl; abstr TPS5604)

DOI

10.1200/JCO.2016.34.15_suppl.TPS5604

Abstract #

TPS5604

Poster Bd #

423b

Abstract Disclosures

Similar Posters

First Author: Paul Sabbatini

First Author: Marcia Hall

First Author: Jeannine A. Villella

First Author: Fernanda Bronzon Damian